Clinical Trials Details

EA5142 ALCHEMIST - SUBSTUDY (Lung)

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL): A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

Clinical Trial Categories

  • Cancers and Other Neoplasms